Skip to content

Drug interactions

Everolimus + Fedratinib

Severity: Moderate

Everolimus and Fedratinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may increase everolimus exposure. This can increase everolimus adverse effects such as mucositis, infections, pneumonitis and myelosuppression.

What this interaction means in plain words

Everolimus and Fedratinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Everolimus belongs to Oncology; Fedratinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Fedratinib inhibits CYP3A4, reducing the metabolic clearance of everolimus.

What to do

Monitor everolimus trough concentrations and adverse effects, and reduce the everolimus dose if levels or toxicity rise. Reassess the dose after fedratinib is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Fedratinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Everolimus with Fedratinib?

MediHelp rates the interaction as moderate. Everolimus and Fedratinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fedratinib is a moderate CYP3A4 inhibitor and may increase everolimus exposure. This can increase everolimus adverse effects such as mucositis, infections, pneumonitis and myelosuppression.

How serious is the interaction between Everolimus and Fedratinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor everolimus trough concentrations and adverse effects, and reduce the everolimus dose if levels or toxicity rise. Reassess the dose after fedratinib is stopped.

What other medicines interact with Everolimus?

MediHelp also lists interactions of Everolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Levoketoconazole. The full list is on the Everolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in